UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 300

Sortiert nach

DNA methylation of the first exon is tightly linked to transcriptional silencing

PloS one, 2011-01, Vol.6 (1), p.e14524-e14524

2011

Volltextzugriff (PDF)

Conversion of adult endothelium to immunocompetent haematopoietic stem cells

Nature (London), 2017-05, Vol.545 (7655), p.439-445

2017

Volltextzugriff (PDF)

Angiocrine Factors Deployed by Tumor Vascular Niche Induce B Cell Lymphoma Invasiveness and Chemoresistance

Cancer cell, 2014-03, Vol.25 (3), p.350-365

2014

Volltextzugriff (PDF)

Ruxolitinib can cause weight gain by blocking leptin signaling in the brain via JAK2/STAT3

Blood, 2020-03, Vol.135 (13), p.1062-1066

2020

Volltextzugriff (PDF)

Reprogramming human endothelial cells to haematopoietic cells requires vascular induction

Nature (London), 2014-07, Vol.511 (7509), p.312-318

2014

Volltextzugriff (PDF)

Molecular Checkpoint Decisions Made by Subverted Vascular Niche Transform Indolent Tumor Cells into Chemoresistant Cancer Stem Cells

Cancer cell, 2017-01, Vol.31 (1), p.110-126

2017

Volltextzugriff (PDF)

Splenomegaly (SPML) in polycythemia vera (PV): its clinical significance and its relation to symptoms, post-polycythemic myelofibrosis (PPMF) and survival

Leukemia, 2023-03, Vol.37 (3), p.691-694

2023

Volltextzugriff (PDF)

Somatic mutations and cell identity linked by Genotyping of Transcriptomes

Nature (London), 2019-07, Vol.571 (7765), p.355-360

2019

Volltextzugriff (PDF)

Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer

Nature medicine, 2013-01, Vol.19 (1), p.50-56

2013

Volltextzugriff (PDF)

Reversal of emphysema by restoration of pulmonary endothelial cells

The Journal of experimental medicine, 2021-08, Vol.218 (8)

2021

Volltextzugriff (PDF)

Excess mortality in younger patients with myeloproliferative neoplasms

Leukemia & lymphoma, 2023-02, Vol.64 (3), p.725-729

2023

Volltextzugriff (PDF)

Defining disease modification in myelofibrosis in the era of targeted therapy

Cancer, 2022-07, Vol.128 (13), p.2420-2432

2022

Volltextzugriff (PDF)

Interferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival

Leukemia, 2021-09, Vol.35 (9), p.2592-2601

2021

Volltextzugriff (PDF)

TGFβ restores hematopoietic homeostasis after myelosuppressive chemotherapy

The Journal of experimental medicine, 2013-03, Vol.210 (3), p.623-639

2013

Volltextzugriff (PDF)

Normal life expectancy for polycythemia vera (PV) patients is possible

Leukemia, 2022-02, Vol.36 (2), p.569-572

2022

Volltextzugriff (PDF)

Megakaryocyte TGFβ1 partitions erythropoiesis into immature progenitor/stem cells and maturing precursors

Blood, 2020-08, Vol.136 (9), p.1044-1054

2020

Volltextzugriff (PDF)

Expression of ENaC subunits in epithelia

The Journal of general physiology, 2022-10, Vol.154 (10), p.1

2022

Volltextzugriff (PDF)

MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis

Journal of clinical oncology, 2023-11, Vol.41 (32), p.4993

2023

Volltextzugriff (PDF)

Development of a vascular niche platform for expansion of repopulating human cord blood stem and progenitor cells

Blood, 2012-08, Vol.120 (6), p.1344-1347

2012

Volltextzugriff (PDF)

Epigenomic Reorganization of the Clustered Hox Genes in Embryonic Stem Cells Induced by Retinoic Acid

The Journal of biological chemistry, 2011-02, Vol.286 (5), p.3250-3260

2011

Volltextzugriff (PDF)

Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia

Haematologica (Roma), 2018-08, Vol.103 (8), p.1308

2018

Volltextzugriff (PDF)

Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response

Clinical cancer research, 2017-06, Vol.23 (11), p.2673-2680

2017

Volltextzugriff (PDF)

PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry

Cancer discovery, 2022-09, Vol.12 (9), p.2120-2139

2022

Volltextzugriff (PDF)

Activation of the vascular niche supports leukemic progression and resistance to chemotherapy

Experimental hematology, 2014-11, Vol.42 (11), p.976-986.e3

2014

Volltextzugriff (PDF)

Disease progression in myeloproliferative neoplasms: comparing patients in accelerated phase with those in chronic phase with increased blasts (<10%) or with other types of disease progression

Haematologica (Roma), 2020-05, Vol.105 (5), p.e221

2020

Volltextzugriff (PDF)

1 – 25 von 300

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(232)
Mit Volltextzugriff
(237)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

DNA methylation of the first exon is tightly linked to transcriptional silencing

Conversion of adult endothelium to immunocompetent haematopoietic stem cells

Angiocrine Factors Deployed by Tumor Vascular Niche Induce B Cell Lymphoma Invasiveness and Chemoresistance

Ruxolitinib can cause weight gain by blocking leptin signaling in the brain via JAK2/STAT3

Reprogramming human endothelial cells to haematopoietic cells requires vascular induction

Molecular Checkpoint Decisions Made by Subverted Vascular Niche Transform Indolent Tumor Cells into Chemoresistant Cancer Stem Cells

Splenomegaly (SPML) in polycythemia vera (PV): its clinical significance and its relation to symptoms, post-polycythemic myelofibrosis (PPMF) and survival

Somatic mutations and cell identity linked by Genotyping of Transcriptomes

Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer

Reversal of emphysema by restoration of pulmonary endothelial cells

Excess mortality in younger patients with myeloproliferative neoplasms

Defining disease modification in myelofibrosis in the era of targeted therapy

Interferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival

TGFβ restores hematopoietic homeostasis after myelosuppressive chemotherapy

Normal life expectancy for polycythemia vera (PV) patients is possible

Megakaryocyte TGFβ1 partitions erythropoiesis into immature progenitor/stem cells and maturing precursors

Expression of ENaC subunits in epithelia

MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis

Development of a vascular niche platform for expansion of repopulating human cord blood stem and progenitor cells

Epigenomic Reorganization of the Clustered Hox Genes in Embryonic Stem Cells Induced by Retinoic Acid

Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia

Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response

PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry

Activation of the vascular niche supports leukemic progression and resistance to chemotherapy

Disease progression in myeloproliferative neoplasms: comparing patients in accelerated phase with those in chronic phase with increased blasts (<10%) or with other types of disease progression

Suchergebnisse filtern